An assistance device for the use with a product dispensing device includes an engaging unit to the dispensing device, a locking unit for locking the dispensing device and configured to prevent or permit dispensing of the product, and a measurement unit for measuring a quantity of the product dispensed by the dispensing device. The locking unit remains unlocked for a predetermined period of time starting from a predetermined activation of the assistance device and then locks automatically at the end of the predetermined period. The locking unit locks automatically when a quantity of the product dispensed during the predetermined period reaches or exceeds a predetermined threshold.

A drug delivery system for delivering a drug product is provided that includes a drug product container containing a drug product, a fluid path adapted to receive the drug product from the drug product container, and a drug delivery device positioned along and/or adjacent to the fluid path. The drug delivery device may include a housing, a fluid displacement assembly at least partially supported by and/or surrounded by the housing, and a drive component at least partially supported by and/or surrounded by the housing. The drive component may drive the medicament through the fluid displacement assembly. Further, the drug delivery device includes a controller workingly coupled with the drive component for controlling the drug delivery device. The controller may operate in a normal operation mode and a reserve mode.

A medicine delivery and tracking system includes a medicine injection pen and a delivery port. The pen includes a needle through which medicine is dispensed and an electronic unit configured to at least one of log dispensing of medicine from the pen, control dispensing of medicine from the pen, or communicate regarding dispensing of medicine from the pen. Alternatively, the electronic unit may be part of a separate computing device. The delivery port is configured for attachment to a user and to receive the needle of the pen such that medicine dispensed from the pen is dispensed into the delivery port and through the delivery port to the user. The delivery port includes a detector mechanism configured to detect a presence of the pen and, in response thereto, to communicate a signal to the electronic unit for use in the at least one of logging, controlling, or communicating.

A system for priming an infusion pump is disclosed. The system includes a priming cap including a septum and configured to matably connect with a male part comprising a needle and attached to a length of tubing for fluid, wherein when matably connected with the male part, the priming cap occludes the tubing.

An infusion pump including a fluid chamber having an outlet valve and a piezo-stack actuator including a stack of piezo-electric layers. The infusion pump also includes a linear actuator to measure displacement of the piezo-stack actuator during operation. An electronic processor is programmed to operate the outlet valve and the piezo-stack actuator to pump fluid through the fluid chamber at a programmed flow rate.

A system and method are provided for detecting air embolisms in lines for hemodynamic monitoring. In use, using a first sensor, one or more gas bubbles are detected within a first line for hemodynamic monitoring. In response to the detecting, a first clamp attached to the first line for hemodynamic monitoring is contracted.

The present invention is generally related to methods and systems for preventing onset or worsening of RHF in patients with implanted ventricular assist devices. More particularly, the present invention relates to identifying patients at risk for RHF following implantation of a ventricular assist device based on pulmonary artery pressure measurement and/or trends and adjusting a pump operating parameter to prevent or reduce the onset or worsening of RHF in such patients, improve patient outcomes, or reduce mortality risks associated with VAD implantation. In particular, a pump operating parameter may be adjusted to reduce or minimize particularly high pressure loads on a patient's heart or amount of time the patient is exposed to such high pressure loads following implantation.

This disclosure describes systems and methods for providing a high pressure controlled proportional assist ventilation breath type during ventilation of a patient. The disclosure describes a novel breath type that reduces ventilator support (or a percent support setting) based on the occurrence of a predetermined number of high pressure alarms.

An infusion device includes a pump configured to deliver a fluid in at least a therapy delivery mode and a stand-by delivery mode. The infusion device includes an audible alarm and at least first, second and third sets of visible indicators. The infusion device includes a pump controller coupled to the pump, the audible alarm, and the visible indicators. The pump controller is configured to operate the pump in the therapy delivery mode or the stand-by delivery mode, and to actuate the first set of visible indicators in the therapy delivery mode and the stand-by delivery mode, to actuate the second set and the audible alarm at an end of the therapy delivery mode and at intervals during the stand-by delivery mode, and to actuate the third set during the stand-by delivery mode when the second set is deactivated.

Devices, systems, and methods are provided herein for delivering medication (e.g., insulin) via a wearable pump having a patch-style form factor for adhesion to a user's body. The reusable pump may be coupled to a disposable cap housing a microdosing system for delivering precise, repeatable doses of medication to a cannula configured to deliver medication to a target infusion area beneath the user's outer skin layer. The system further may include an applicator for inserting the cannula into the user's skin and/or applying an adhesive pad to the skin.